Hims & Hers 10-Q: $890M Q3 Revenue, $33M Net Loss, $60M FTC Legal Accrual
HIMS sits 70% above its 52-week low of $13.74 on elevated volume (4.1× avg).
Summary
Hims & Hers' Q3 10-Q confirms 49% revenue growth to $890.4 million but a $33.0 million net loss on a 57% gross margin, and adds a $60 million FTC legal accrual, an SEC investigation disclosure and a $114.8 million working capital deficit.
Key Events · Earnings and Guidance · HIMS
-
Q3 Revenue Up 49%, Quarter Turns to Loss
Revenue was $890.4 million versus $599.0 million a year earlier, but the quarter produced a $33.0 million net loss versus $15.8 million of net income in Q3 2025.
-
Gross Margin Collapses to 57%
Gross margin fell to 57% from 74% as cost of revenue rose 143% to $381.2 million, driven by branded weight-loss product costs, shorter shipping cadences and recent acquisitions.
-
$60M FTC Legal Accrual Booked
The company recorded a $60 million legal contingency accrual for the FTC complaint filed July 29, 2026; its motion to dismiss is set for hearing January 14, 2027.
-
SEC Investigation and Cyber Incident Disclosed
The 10-Q discloses a February 2026 SEC Enforcement investigation into statements on compounded semaglutide and a February 2026 social-engineering cyber incident affecting two employees.
Analysis · HIMS · Industrial Applications And Services
The headline numbers were already out via this morning's 8-K, but the full 10-Q carries the detail that actually changes the risk picture. Gross margin collapsed to 57% from 74% as the weight-loss mix shifted to branded GLP-1s and shorter shipping cadences, turning a $15.8 million profit a year ago into a $33.0 million loss. The filing also puts a hard number on the FTC fight — a $60 million accrual — and discloses a February 2026 SEC Enforcement investigation plus a social-engineering cyber incident, neither of which was in the earnings release. Liquidity looks adequate ($712.2 million of cash and investments, $161.0 million undrawn on the revolver), but the balance sheet now carries a $114.8 million working capital deficit from the Eucalyptus deferred consideration and $1.4 billion of convertible notes.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HIMS was trading at $23.39 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $13.74 to $42.70. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.